KAPA - Kairos Pharma, LTD.

QQQ $ 617.51 $ 0.00 (0 %)

DIA $ 470.86 $ 0.00 (0 %)

SPY $ 674.17 $ 0.00 (0 %)

TLT $ 89.88 $ 0.00 (0 %)

GLD $ 364.84 $ 0.00 (0 %)

Previous Close

$ 0.8674

Open

$ 1.00

Bid

$ 0.87 x 2,700

Ask

$ 0.95 x 39,570

Day's Range

-- - --

52 Week Range

$ 0.40 - $ 3.25

Volume

868,875

Average Volume

Market Cap

14.93M

Beta (5Y Monthly)

$ 0.42

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-14-2025	03-31-2025	10-Q
3	04-15-2025	12-31-2024	10-K
4	11-14-2024	09-30-2024	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

D. Boral Capital Maintains Buy on Kairos P...
11/04/2025 14:30:55

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

D. Boral Capital Maintains Buy on Kairos P...
10/20/2025 13:29:23

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Kairos Pharma Presents Phase 2 Trial Of EN...
10/20/2025 12:08:06

Interim efficacy analysis highlights potential value of combination therapy of ENV-105 and apalutamide following positive safet...

D. Boral Capital Maintains Buy on Kairos P...
10/07/2025 14:50:30

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

Kairos Pharma To Present Phase 2 Data On A...
10/07/2025 12:05:11

Kairos Pharma, Ltd. (NYSE:KAPA), a clinical-stage biopharmaceutical company dedicated to addressing resistance to current cance...

12 Health Care Stocks Moving In Friday's I...
09/19/2025 17:06:19

D. Boral Capital Maintains Buy on Kairos P...
09/19/2025 11:15:47

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

why-fedex-shares-are-trading-higher-by-5-here-are-20-stocks-moving-premarket

Why FedEx Shares Are Trading Higher By 5%;...
09/19/2025 09:25:20

Kairos Pharma Announces Efficacy Data From...
09/18/2025 12:05:18

Interim efficacy analysis highlights potential value of combination therapy of apalutamide and ENV105 following positive safety...

Kairos Pharma To Present Initial Phase 1 D...
09/03/2025 12:16:13

Kairos Pharma, Ltd. (NYSE:KAPA), a clinical-stage biopharmaceutical company focused on innovative cancer therapeutics, today an...

why-carisma-therapeutics-shares-are-trading-higher-by-133-here-are-20-stocks-moving-premarket

Why Carisma Therapeutics Shares Are Tradin...
09/02/2025 09:28:56

Kairos Pharma Q2 EPS $(0.08) Misses $(0.05...
08/12/2025 21:37:25

Kairos Pharma (AMEX:KAPA) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.05)...

12 Health Care Stocks Moving In Wednesday'...
07/30/2025 21:06:56

12 Health Care Stocks Moving In Thursday's...
07/17/2025 12:08:10

12 Health Care Stocks Moving In Wednesday'...
07/16/2025 21:06:00

12 Health Care Stocks Moving In Wednesday'...
07/16/2025 12:08:15

D. Boral Capital Maintains Buy on Kairos P...
07/16/2025 11:37:17

D. Boral Capital analyst Jason Kolbert maintains Kairos Pharma (AMEX:KAPA) with a Buy and maintains $9 price target.

why-data-storage-shares-are-trading-higher-by-35-here-are-20-stocks-moving-premarket

Why Data Storage Shares Are Trading Higher...
07/16/2025 10:04:22

12 Health Care Stocks Moving In Tuesday's ...
07/15/2025 21:06:55

why-is-kairos-pharma-stock-surging-on-tuesday

Why Is Kairos Pharma Stock Surging On Tues...
07/15/2025 18:08:07

Kairos Pharma reported strong safety results from a Phase 2 trial of ENV-105 in mCRPC, with no serious toxicities seen in the f...